Arlington Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$609K Hold
508
0.08% 60
2026
Q1
$467K Hold
508
0.07% 64
2025
Q4
$546K Hold
508
0.08% 61
2025
Q3
$388K Hold
508
0.06% 73
2025
Q2
$396K Sell
508
-142
-22% -$110K 0.06% 60
2025
Q1
$537K Buy
650
+142
+28% +$118K 0.09% 73
2024
Q4
$392K Buy
508
+75
+17% +$62.1K 0.08% 69
2024
Q3
$384K Hold
433
0.08% 57
2024
Q2
$392K Hold
433
0.09% 56
2024
Q1
$337K Buy
433
+67
+18% +$47.7K 0.07% 62
2023
Q4
$213K Buy
+366
New +$214K 0.06% 76

Other funds holding LLY

Arlington Financial Advisors's LLY Position: Q2 2026 in Review

Arlington Financial Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 508 shares worth $609K. The position accounts for 0.08% of the portfolio, ranked #60.

Arlington Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Arlington Financial Advisors held 508 shares of Eli Lilly worth $609K as of Q2 2026.
  • Arlington Financial Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.08% of Arlington Financial Advisors's portfolio in Q2 2026, its #60 holding.
  • Arlington Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arlington Financial Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.